Table 1.
Year | First Author | Prevalence | Group Type | Sample Size | Reference |
---|---|---|---|---|---|
1998 | Kakumu | 1% | General Population | 1179 | [47] |
2007 | Nguyen | 1% | General Population | 837 | [45] |
2015 | Quesada | 4.7% | General Population | 27/571 | [27] |
2015 | Do | 3.3% 1.3%* |
General population | 509 | [30] |
2003 | Tran | 2% | General population | 334 | [15] |
1996 | Corwin | 2% | General population | 188 | [49] |
2012 | Sereno | 0.38–4.3% | General population | NAb | [21] |
2016 | Martinello | 42.5% | HIV | 89.452a | [24] |
2015 | Nadol | 53.3% | HIV/IDU | 3010 | [32] |
2015 | Zang | 88% | HIV | 1434 | [29] |
1999 | Follézou | >80% | HIV | 280 | [18] |
2012 | Durier | 22.9% | HIV | 110 | [20] |
2016 | Nguyen | 89% | HIV | 104 | [26] |
2016 | Hser | 74% | HIV/IDU | NAb, c | [11] |
2012 | Sereno | 95.8% | HIV/IDU | NAb | [21] |
2012 | Gish | 87% | IDU | NAb | [36] |
1998 | Kakumu | 47% | Liver Disease | 1179 | [47] |
2003 | Tran | 10% | Liver disease | 334 | [15] |
1996 | Corwin | 10% | Liver Disease | 188 | [49] |
2004 | Buchy | 9% | Liver disease | 45 | [46] |
2012 | Gish | 23% | Liver disease | NAb | [36] |
1993 | Cordier | 2% | Hepatocarcinoma | 152 | [54] |
2010 | Bjoerkvoll | 12.7% | Blood donors | 1305 | [38] |
2012 | Viet | 76.4% | Blood Donors | 1200a | [40] |
1994 | Song | 20.6% | Blood Donors | 491 | [52] |
2012 | Dunford | 26.6% | Dialysis | 8652a | [37] |
2016 | Duong | 8% | Dialysis | 142 | [22] |
2015 | Duong | 6% | Dialysis | 113 | [31] |
2012 | Gish | 54% | Hemodialysis | NAb | [36] |
2016 | Nadol | 28.4% | MSM | 1588 | [25] |
2012 | Dunford | 8.7% | CSW | 8652a | [37] |
*Presence of HCV RNA
aMulti countries study
b NA Not applicable
cEstimate